Luigi Mangione’s defense slams plea deal reports, drops emotional distress claim
Attorneys for accused CEO killer Luigi Mangione are condemning reports suggesting a potential plea agreement with federal prosecutors, arguing the claims fit into what they describe as a coordinated effort to influence public perception and undermine his right to a fair trial. The defense has also dropped an emotional distress argument in Mangione’s state murder case, a claim that could have helped lower the charge from murder to manslaughter.
Lawyers for Luigi Mangione are pushing back against accounts that the suspect in the UnitedHealthcare CEO assassination case has been negotiating a federal plea deal.
WNBC reported Thursday, citing unnamed sources, that Mangione had communicated with federal prosecutors about a possible plea arrangement. The station also reported, again based on anonymous sources, that a deal had been nearing completion before ultimately collapsing.
In a statement provided to Fox News, Mangione attorney Karen Friedman Agnifilo accused prosecutors of attempting to steer public opinion surrounding the case, though she did not directly confirm or deny whether plea discussions had taken place.
“This information attributed to ‘anonymous sources’ is part of a troubling, deliberate pattern by prosecutors and law enforcement to prejudice Luigi, manipulate public opinion, and violate his constitutional right to a fair trial and impartial jury,” Agnifilo said.
Luigi Mangione appears at a pre-trial hearing in Manhattan Criminal Court in New York, N.Y., on June 17, 2026. (Barry Williams/New York Daily News)
“Every defendant in America is presumed innocent until proven guilty, including Luigi, who, unlike any other defendant, has to fight the same charges twice,” she added.
Mangione is still charged federally with two counts of stalking resulting in death. Earlier in 2026, two additional counts — murder through the use of a firearm and a weapons charge — were dismissed. The now-dismissed federal murder count had carried potential death penalty eligibility.
The U.S. attorney’s office declined to comment when reached by Fox News.
Luigi Mangione appears at a pretrial hearing in Manhattan Criminal Court in New York City on June 17, 2026. Mangione is accused of murdering UnitedHealthcare CEO Brian Thompson in December 2024. (Barry Williams/New York Daily News)
ALSO READ: 12 Signs of Walking Pneumonia in Adults: How to Identify this Subtle Illness
Shortly after informing the court that they plan to pursue a psychiatric defense for Mangione, his lawyers suddenly withdrew the “extreme emotional disturbance” defense plan.
Under New York law, if the claim was accepted by jurors following his conviction, it had the potential to reduce a murder verdict to first-degree manslaughter.
Randolph Rice, a Maryland-based attorney and legal analyst, told News Agency he thinks Mangione changed his mind after realizing this defense could open him up to more issues.
Brian Thompson was named CEO of UnitedHealthcare Unit in 2017. He was shot in New York City in December 2024. (Businesswire)
“He might have had a change of heart and said, ‘Wait a second, I’m going into state court. I’m admitting that I did this. How is this going to play when I’m facing even more serious charges in federal court in January of next year?'” Rice said.
Criminal defense attorney James Leonard called the initial defense plan “a very risky trial strategy.”
Luigi Mangione arrives at an evidence suppression hearing at the Manhattan Supreme Court in New York City on May 18, 2026. (Jeenah Moon/Reuters via Pool)
“They are basically telling the jury that Mangione committed the murder, but here is why he did it and, because of this, you should nullify his guilt,” Leonard said. “If the jury accepts that, it would be an epic win for the defense team. If the jury rejects that, it [would] likely mean that Mangione will spend the rest of his life behind bars.”
